rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

03 Jul,15:28
6362.80
-3.85 (-0.06%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

637 6,366.65 6,511.00 - 6,349.60 7,208.00 - 3,650.05 15,907.00
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

03 Jul,15:42
6398.10
34.20 (0.54%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

15,550 6363.90 6,514.90 - 6,350.00 7,220.95 - 3,698.05 100,158,327.50

News for AstraZeneca Pharma India Ltd.

AstraZeneca...
AstraZeneca Withdraws COVID Vaccine: Surplus of Updated Vaccines
AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...
May 08, 2024 14:34
AstraZeneca...
AstraZeneca Withdraws COVID-19 Vaccine: Surplus of Updated Shots
AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.
May 08, 2024 11:12
Covaxin Safe, No...
Covaxin Safe, No Side Effects: Bharat Biotech
Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.
May 02, 2024 21:41
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:17
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin has received USFDA approval to market a generic medication for type 2 diabetes, a generic equivalent of AstraZeneca's Qtern tablets. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:12

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

CoinDCX Acquires...
CoinDCX Acquires BitOasis: Expanding Crypto Reach in MENA
India's CoinDCX acquires BitOasis, the leading crypto exchange in the Middle East and North Africa, expanding its reach and boosting crypto adoption in the region.
Jul 03, 2024 20:58
AI Fears vs....
AI Fears vs. Opportunities: MEITY Secy's Perspective
India's potential to leverage AI outweighs the fears, says MEITY Secretary, highlighting opportunities for Indian youth and the need for regulations to mitigate risks.
Jul 03, 2024 20:53
BSNL 4G, 5G...
BSNL 4G, 5G Delay: Tariff Hike Concerns - Telecom News
BSNL Employees Union criticizes private telcos' tariff hikes, blaming lack of 4G, 5G services by BSNL for no restraint on pricing. Learn about the latest developments.
Jul 03, 2024 20:14
Supertech...
Supertech Realtors Insolvency Case: NCLAT Awaits Lenders' Decision
NCLAT delays insolvency proceedings against Supertech Realtors, pending lenders' decision on a revised settlement offer. The Supernova project, under construction, will continue under IRP supervision.
Jul 03, 2024 20:12
AI Regulations:...
AI Regulations: India Seeks Political Consensus - Vaishnaw
India is actively discussing AI regulations, with Union Minister Ashwini Vaishnaw highlighting the need for political consensus. The government aims to ensure responsible AI development and...
Jul 03, 2024 20:07

More News »

Top News

CoinDCX Acquires...
CoinDCX Acquires BitOasis: Expanding Crypto Reach in MENA
India's CoinDCX acquires BitOasis, the leading crypto exchange in the Middle East and North Africa, expanding its reach and boosting crypto adoption in the region.
Jul 03, 2024 20:58
AI Fears vs....
AI Fears vs. Opportunities: MEITY Secy's Perspective
India's potential to leverage AI outweighs the fears, says MEITY Secretary, highlighting opportunities for Indian youth and the need for regulations to mitigate risks.
Jul 03, 2024 20:53
BSNL 4G, 5G...
BSNL 4G, 5G Delay: Tariff Hike Concerns - Telecom News
BSNL Employees Union criticizes private telcos' tariff hikes, blaming lack of 4G, 5G services by BSNL for no restraint on pricing. Learn about the latest developments.
Jul 03, 2024 20:14
Supertech...
Supertech Realtors Insolvency Case: NCLAT Awaits Lenders' Decision
NCLAT delays insolvency proceedings against Supertech Realtors, pending lenders' decision on a revised settlement offer. The Supernova project, under construction, will continue under IRP supervision.
Jul 03, 2024 20:12
ED Arrests 3 in...
ED Arrests 3 in Fraudulent Company Takeover
The Enforcement Directorate (ED) has arrested 3, including a CA, for allegedly defrauding a consortium of banks and regaining control of an insolvent company.
Jul 03, 2024 20:12

More Top News »

Report Card

PE Ratios
98.85
EPS (Rs.)
64.60
Sales (Rs. Cr)
383.20
Face Value (Rs.)
2
Net Profit Margin (%)
9.89
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
16.86

BSE Announcements from AstraZeneca Pharma India Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 6 day(s) ago
announcement Record Date For Payment Of Final Dividend - 25 Jun 2024

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,517.90
  • Compare
  • Divi's Laboratories Ltd.
  • 4,599.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,066.95
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,351.50
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,779.40
  • Compare
  • Max Healthcare Institute Ltd.
  • 955.05
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,137.05
  • Compare
  • Alkem Laboratories Ltd.
  • 4,956.50
  • Compare

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close